Spectrum Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Spectrum Pharmaceuticals, Inc.‘s stocks are currently a part of 76 hedge funds’ portfolios, which represents 34.44% of the total amount of its stocks outstanding. This makes up a total of 58.45M shares of Spectrum Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -18.14% or -12.95M shares fewer. As for the holding position changes, 23.68% (18) of current hedge fund investors increased the number of shares held, 28.95% (22) of current holders sold a part of the shares held, and 40.79% (31) closed the holdings completely. 18 hedge funds are new holders of Spectrum Pharmaceuticals, Inc. stock in Q2 2022, it is 23.68% of total holders.
Hedge funds holding Spectrum Pharmaceuticals (Q3 2017 – Q2 2022)
| Q3 2017 | 153 |
|---|---|
| Q4 2017 | 152 |
| Q1 2018 | 155 |
| Q2 2018 | 176 |
| Q3 2018 | 183 |
| Q4 2018 | 168 |
| Q1 2019 | 165 |
| Q2 2019 | 155 |
| Q3 2019 | 159 |
| Q4 2019 | 160 |
| Q1 2020 | 144 |
| Q2 2020 | 150 |
| Q3 2020 | 149 |
| Q4 2020 | 152 |
| Q1 2021 | 139 |
| Q2 2021 | 147 |
| Q3 2021 | 139 |
| Q4 2021 | 133 |
| Q1 2022 | 90 |
| Q2 2022 | 76 |
Hedge funds changes in Spectrum Pharmaceuticals positions (Q3 2017 – Q2 2022)
| Q3 2017 | 44 | 61 | 22 | 11 | 15 |
|---|---|---|---|---|---|
| Q4 2017 | 31 | 69 | 36 | 32 | -16 |
| Q1 2018 | 25 | 59 | 48 | 20 | 3 |
| Q2 2018 | 38 | 72 | 40 | 16 | 10 |
| Q3 2018 | 33 | 76 | 50 | 24 | 0 |
| Q4 2018 | 15 | 68 | 55 | 30 | 0 |
| Q1 2019 | 19 | 76 | 37 | 23 | 10 |
| Q2 2019 | 15 | 80 | 27 | 22 | 11 |
| Q3 2019 | 22 | 72 | 36 | 18 | 11 |
| Q4 2019 | 28 | 52 | 50 | 21 | 9 |
| Q1 2020 | 22 | 44 | 45 | 36 | -3 |
| Q2 2020 | 23 | 58 | 36 | 16 | 17 |
| Q3 2020 | 20 | 78 | 26 | 21 | 4 |
| Q4 2020 | 22 | 56 | 42 | 20 | 12 |
| Q1 2021 | 10 | 44 | 51 | 22 | 12 |
| Q2 2021 | 21 | 65 | 33 | 12 | 16 |
| Q3 2021 | 16 | 46 | 43 | 23 | 11 |
| Q4 2021 | 33 | 33 | 49 | 38 | -20 |
| Q1 2022 | 13 | 17 | 43 | 55 | -38 |
| Q2 2022 | 18 | 18 | 22 | 31 | -13 |
Hedge funds changes in Spectrum Pharmaceuticals stock options (Q3 2017 – Q2 2022)
| Q3 2017 | 6,155,000 | 2,090,000 |
|---|---|---|
| Q4 2017 | 8,265,000 | 1,000,024,116,000 |
| Q1 2018 | 8,282,000 | 14,028,000 |
| Q2 2018 | 20,055,000 | 10,357,000 |
| Q3 2018 | 21,249,000 | 18,169,000 |
| Q4 2018 | 684,000 | 1,278,000 |
| Q1 2019 | 727,000 | 1,657,000 |
| Q2 2019 | 342,000 | 13,591,000 |
| Q3 2019 | 3,810,000 | 13,957,000 |
| Q4 2019 | 5,653,000 | 5,120,000 |
| Q1 2020 | 241,000 | 369,000 |
| Q2 2020 | 197,000 | 340,000 |
| Q3 2020 | 532,000 | 606,000 |
| Q4 2020 | 336,000 | 778,000 |
| Q1 2021 | 297,000 | 851,000 |
| Q2 2021 | 411,000 | 1,469,000 |
| Q3 2021 | 879,000 | 791,000 |
| Q4 2021 | 100,000 | 406,000 |
| Q1 2022 | 432,000 | 84,000 |
| Q2 2022 | 480,000 | 35,000 |